• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Zhongchao Inc.

    2/20/24 4:00:14 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate
    Get the next $ZCMD alert in real time by email
    6-K 1 ea0200269-6k_zhongchao.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of February 2024

     

    ZHONGCHAO INC.

    (Exact name of registrant as specified in its charter)

     

    Nanxi Creative Center, Suite 218

    841 Yan’an Middle Road

    Jing’An District, Shanghai, China 200040

    Tel: 021-32205987 (Address of Principal Executive Office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F  ☒      Form 40-F  ☐

     

     

     

     

     

     

    Submission of Matters to a Vote of Security Holders.

     

    On February 20, 2024, Zhongchao Inc., a Cayman Islands exempt company (the “Company”) held an extraordinary general meeting of shareholders (the “Meeting”) at 9:00 a.m. Eastern Time, at the offices of Robinson & Cole LLP located at 666 Third Avenue, 20th Floor, New York, NY 10017. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to a hundred votes. Holders of a total of 8,373,826 ordinary shares (consisting of 2,876,111 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares), out of a total of 24,697,070 shares (consisting of 19,199,355 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares) issued and outstanding and entitled to vote at the Meeting have voted. Therefore, a quorum of more than a third of all votes attaching to the total issued voting shares in the Company at the Meeting as of the record date of January 12, 2024 was reached. The final voting results for each matter submitted to a vote of shareholders at the Meeting are as follows:

     

    1. The Share Consolidation

     

    It was approved, by way of ordinary resolutions, to effect a share consolidation of the Company’s ordinary shares at a ratio of one-for-ten such that each ten (10) Class A ordinary shares with a par value $0.0001 each, are consolidated into one (1) Class A ordinary share with a par value $0.001 each, and that each ten (10) Class B ordinary shares with a par value $0.0001 each, are consolidated into one (1) Class B ordinary share, par value $0.001 per share (the “Share Consolidation”). As a result of the Share Consolidation, the authorised share capital of the Company will be amended from $50,000 divided into 450,000,000 Class A Ordinary Shares with a par value of $0.0001 each and 50,000,000 Class B Ordinary Shares with a par value of $0.0001 each to $50,000 divided into 45,000,000 Class A ordinary shares with a par value of $0.001 each and 5,000,000 Class B ordinary shares with a par value of $0.001 each.

     

    For   Against   Abstain
    552,627,145   20,116   350

     

    2. The Share Capital Increase

     

    It was approved, by way of ordinary resolutions, that following the Share Consolidation being effected, the authorized share capital of the Company be increased to $500,000 divided into 450,000,000 Class A Ordinary Shares with a par value of $0.001 each and 50,000,000 Class B Ordinary Shares with a par value of $0.001 each (the “Share Capital Increase”).

     

    For   Against   Abstain
    552,603,312   43,999   300

     

    3. Amendment of the Amended and Restated Articles of Association

     

    It was approved, by way of special resolutions, to amend the Company’s amended and restated memorandum and articles of association as currently in effect to reflect typographical corrections, the Share Consolidation and the Share Capital Increase.

     

    For   Against   Abstain
    552,603,599   43,662   350

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Zhongchao Inc.
       
    Date: February 20, 2024 By: /s/ Weiguang Yang
        Weiguang Yang
    Chief Executive Officer

     

    2

     

    Get the next $ZCMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZCMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZCMD
    SEC Filings

    View All

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    2/10/26 4:00:40 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/27/26 5:15:28 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by Zhongchao Inc.

    6-K - Zhongchao Inc. (0001785566) (Filer)

    1/20/26 5:20:41 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

    SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment. SLE is a chronic inflammatory autoimmune disease that affects multipl

    3/12/24 8:30:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Announces 1-for-10 Share Consolidation

    SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that an extraordinary general meeting of shareholders held on Tuesday, February 20, 2024, approved the proposed 1-for-10 share consolidation of the Company's ordinary shares of US$0.0001 par value each (the "Share Consolidation"). Beginning with the opening of trading on February 29, 2024, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP num

    2/27/24 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

    SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ:ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement (the "Agreement") with Beijing Public Health Foundation ("BPHF"), a non-profit organization dedicated to enhancing Chinese citizens' health through public welfare initiatives and aid programs. Pursuant to the Agreement, Zhongxin and BPHF extended its par

    12/11/23 8:00:00 AM ET
    $ZCMD
    Other Consumer Services
    Real Estate

    $ZCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by ZHONGCHAO INC. (Amendment)

    SC 13D/A - Zhongchao Inc. (0001785566) (Subject)

    5/21/21 5:10:06 PM ET
    $ZCMD
    Other Consumer Services
    Real Estate